Delivery Order SPE2DB20D1100-SPE2DB23FD6U2

Award Date 9/18/23
Potential Completion Date 9/19/23
Potential Value $3.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $18,165.49, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DALIRESP 500 MCG TABLET 90S, a pharmaceutical product. The award has a completion date of September 9, 2022 and was issued on a firm fixed-price basis. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order for the pharmaceutical product DALIRESP 250 MCG TABLET. The $1,128.99 award was made by the Defense Logistics Agency (DLA) and has a completion date of September 17, 2021. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides delivery orders for the pharmaceutical product Daliresp 500 mcg tablet. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order valued at $3,777.63 with a period of performance through November 3, 2023. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
This federal contract award is a delivery order (SPE2DB20D3505|SPE2DB24FT2W2) worth $1,099.55 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is from the Defense Logistics Agency (DLA) for the pharmaceutical product DALIRESP 500 MCG TABLET 30S. The contract has an ultimate completion date of October 25, 2023 and is a firm fixed price agreement. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Daliresp 250 mcg tablets to the Defense Logistics Agency (DLA). The $2,671.64 firm-fixed-price delivery order is the latest in a series of contracts between Amerisourcebergen and the DLA, with the company holding a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $39,922.10, is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. This is a Firm Fixed Price delivery order contract with an ultimate completion date of September 19, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also registered in the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of DALIRESP 500 MCG TABLET 90S. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, has a ceiling value of $20,496.82 and was placed as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of...
This federal contract award, valued at $2,452.64, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract covers the delivery of DALIRESP 250 MCG TABLET in quantities of 28. This is a Firm Fixed Price, Delivery Order contract with a period of performance ending on June 17, 2022. The contract was awarded on June 16, 2022 and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,118.73 firm fixed-price delivery order is for the supply of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 25, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $4,795.77, is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which covers a comprehensive range of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB23FD6U2
    Delivery Order

This federal contract award, valued at $3,196.06, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of DALIRESP 500 MCG TABLET 30S, a pharmaceutical product. This is a delivery order contract with a firm fixed price. The contract does not have a set-aside designation, indicating it was awarded through full and open competition.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 5/12/25, 10:27 AM